INS and type 2 diabetes mellitus: We carried forwards CpGs identified in EWAS for type 2 diabetes and meta-analysed EWAS for HbA<sub>1c</sub> and homeostatic model assessment estimates of insulin sensitivity (HOMA-S) as exposures to two-sample MR analysis.